Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann E Wasmuth

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
The Journal of Clinical Investigation|October 28, 2010
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceMarie-Luise Berres, Rory R Koenen, Anna Rueland, et al.
Cells|February 2, 2021
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell PopulationsDaniel Heinrichs, Elisa F Brandt, Petra Fischer, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Hepatology (Baltimore, Md.)|January 13, 2012
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in miceHacer Sahin, Erawan Borkham-Kamphorst, Christoph Kuppe, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
The Journal of Clinical Investigation|October 28, 2010
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceMarie-Luise Berres, Rory R Koenen, Anna Rueland, et al.
Cells|February 2, 2021
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell PopulationsDaniel Heinrichs, Elisa F Brandt, Petra Fischer, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Hepatology (Baltimore, Md.)|January 13, 2012
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in miceHacer Sahin, Erawan Borkham-Kamphorst, Christoph Kuppe, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Pageof 8